Villejuif, France, February 17, 2023 at 6:30 p.m. CET – PREDILIFE
(Euronext Growth: ALPRE FR0010169920), a specialist in artificial intelligence methods for predicting the risks of pathologies for personalized medicine, announces today the publication of its Universal Registration Document.
This document, which provides complete information on the Company, was approved by the Autorité des Marchés Financiers (AMF) on February 16, 2023 under number R.23-005. It is made available to the public free of charge under the conditions provided for by the regulations in force and can be consulted on the company’s website in the section Press releases and publications / Regulated information, as well as on that of the AMF (www. amf-france.org).
The Universal Registration Document notably includes the financial statements for the fiscal year ended December 31, 2021 and the half-year ended June 30, 2022, as well as the related auditor’s reports.
About Predilife
PREDILIFE is a pioneer in the design and development of predictive tests intended to prevent the main diseases. It uses artificial intelligence methods applied to clinical and genetic medical data in a secure legal framework. The prediction of these individual risks makes it possible to propose a personalized monitoring protocol and earlier identification of pathologies.
For more information: www.predilife.com
|
contacts PREDILIFE Investor Relations Stephane Ragusa Chairman and CEO CAPVALUE Press Relations |
This post has the “? Actusnews SECURITY MASTER” service.
– SECURITY MASTER Key:
nJpulpptl5eXm22elslnbmZoa5qSxJaYmJeVlJeeapfFa2pmyGaUa5udZnBpm2ln
– To check this key:
https://www.security-master-key.com.
Regulated information:
Press releases for the availability of documents:
– Methods of making available the universal registration document or its updates
Full and original press release in PDF format:
https://www.actusnews.com/news/78641-cp_deu17022023_vf.pdf
© Copyright Actusnews Wire
Receive the company’s next press releases free of charge by email by subscribing to www.actusnews.com